Actavis names EVP, global chief compliance officer

DUBLIN — Specialty pharmaceutical company Actavis has hired Jonathon Kellerman as EVP, global chief compliance officer.  



Kellerman will report to Brent Saunders, CEO and president. He also will be an integral member of the Actavis and Allergan pre-integration planning team as well as integration activities following the close.



Kellerman joins Actavis from PwC, where he was a partner in PwC's Pharmaceutical and Life Sciences Advisory practice, responsible for helping lead the firm's Governance, Risk & Compliance practice, including a global team of more than 100 professionals.



Kellerman brings extensive experience in compliance and sales and marketing performance improvement, including global anti-bribery/anti-corruption program assessment, design and implementation work; building and implementing effective global compliance programs; managing fraud investigations and remediation activities; re-engineering processes supporting key commercial and R&D business activities and compliance controls; and re-designing how companies engage health care professionals. He has also led major "rapid response" organizational and business process improvement initiatives across multiple business and support functions.



Earlier in his career, Kellerman worked in healthcare consulting for Zelenkofske Axelrod and in research for Blank Rome.